TransMedics Group, Inc. Common Stock

TMDXNASDAQUSD
67.84 USD
5.06 (6.94%)AT CLOSE (11:59 AM EDT)
68.44
0.60 (0.88%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
68.44
0.60 (0.88%)
🔴Market: CLOSED
Open?$72.54
High?$72.73
Low?$67.69
Prev. Close?$72.90
Volume?2.7M
Avg. Volume?1.2M
VWAP?$68.71
Rel. Volume?2.20x
Bid / Ask
Bid?$68.30 × 100
Ask?$68.68 × 100
Spread?$0.38
Midpoint?$68.49
Valuation & Ratios
Market Cap?2.5B
Shares Out?34.6M
Float?33.1M
Float %?96.4%
P/E Ratio?14.65
P/B Ratio?5.10
EPS?$4.97
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Employees
898
Market Cap
2.3B
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Listed
2019-05-02
Address
200 MINUTEMAN ROAD
ANDOVER, MA 01810
Phone: (978) 552-0900
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.74Strong
Quick Ratio?6.19Strong
Cash Ratio?5.02Strong
Debt/Equity?1.73High
ValuationFAIRLY VALUED
Score
72/100
P/E?
14.7CHEAP
P/B?
5.10FAIR
P/S?
3.96FAIR
P/FCF?
16.7CHEAP
EV/EBITDA?
22.9HIGH
EV/Sales?
4.58FAIR
Returns & Efficiency
ROE?
34.8%STRONG
ROA?
12.0%STRONG
Cash Flow & Enterprise
FCF?$151.4M
Enterprise Value?$2.9B
Fundamentals ratios updated end of day